Slow-cycling BRAF melanoma cells are notoriously resistant to standard chemotherapy or targeted therapy but the underlying mechanism remains elusive. Now a new study unlocks this mystery and offers novel insights into developing more effective therapeutic interventions. © 2014 IBCB, SIBS, CAS.
CITATION STYLE
Zhang, G., & Herlyn, M. (2014). Linking SOX10 to a slow-growth resistance phenotype. Cell Research, 24(8), 906–907. https://doi.org/10.1038/cr.2014.67
Mendeley helps you to discover research relevant for your work.